NMR spectroscopy of human post mortem cerebrospinal fluid: Distinction of Alzheimer's disease from control using pattern recognition and statistics

1H NMR spectra have been measured at 500 and 600 MHz on 23 human cerebrospinal fluid samples obtained at autopsy from Alzheimer's disease patients and controls. The spectra at 500 MHz were quantified using 42 descriptors based on NMR peak heights and it was shown that differences between the two classes were apparent in the δ2.4–2.9 region. Remeasured at 600 MHz a detailed examination of this chemical shift range identified citrate, aspartate, N‐acetyl aspartate, methionine and glutamate in this region of the spectra. Principal components analysis showed that a separation of the two classes was possible and detailed statistics indicated that citrate level was the principal marker. Patient age and the interval between death and autopsy (parameters not closely matched between the two groups) were examined statistically to establish whether these might account for the citrate differences. Although they could possibly account for them to some extent, the relationship between citrate levels and disease state remained significant at p<0.05. The data invite a test of the importance of citrate levels in Alzheimer's disease using samples taken ex vivo.

[1]  Ian D. Wilson,et al.  HIGH RESOLUTION PROTON MAGNETIC RESONANCE SPECTROSCOPY OF BIOLOGICAL FLUIDS , 1989 .

[2]  Z. Khachaturian Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[3]  W. Russell,et al.  Motor neurone disease , 1971, Journal of neurology, neurosurgery, and psychiatry.

[4]  E. Perry,et al.  Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase , 1980, Neuroscience Letters.

[5]  C. Snehalatha,et al.  Biochemical aspects of motor neurone disease—Madras pattern , 1973, Journal of Neurology Neurosurgery & Psychiatry.

[6]  W. Jagust,et al.  Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease , 1988, Magnetic resonance in medicine.

[7]  J C Lindon,et al.  Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data , 1990, NMR in biomedicine.

[8]  D. Saffer,et al.  Carbohydrate metabolism in motor neurone disease. , 1977, Journal of neurology, neurosurgery, and psychiatry.

[9]  Jimmy D Bell,et al.  High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. , 1987, Clinical science.

[10]  R. Levy,et al.  Accuracy of clinical diagnosis of Alzheimer's disease. , 1990, BMJ.

[11]  J A Helpern,et al.  In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia , 1989, Neurology.

[12]  O. Petroff,et al.  High‐Resolution Proton Magnetic Resonance Analysis of Human Cerebrospinal Fluid , 1986, Journal of neurochemistry.

[13]  J. Blair,et al.  Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type. , 1983, Journal of neurology, neurosurgery, and psychiatry.

[14]  J C Lindon,et al.  Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. , 1991, Molecular pharmacology.

[15]  E. Wood,et al.  Data for Biochemical Research, 3rd Edn , 1987 .

[16]  T. Nakada,et al.  Elevation in relative levels of brain membrane unsaturated fatty acids in Alzheimer's disease: High resolution proton spectroscopic studies of membrane lipid extracts , 1991, Magnetic resonance in medicine.

[17]  S. Karp Meningitis and disseminated cutaneous zoster complicating herpes zoster infection. , 1983, Journal of neurology, neurosurgery, and psychiatry.